P

Inventor

PRIEBE WALDEMAR

US42 patents
⚠️ This page may combine multiple inventors who share the name “PRIEBE WALDEMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV TEXAS

19 patents
US4863739ASep 5, 1989

Liposome compositions of anthracycline derivatives

UNIV TEXAS24 citations92
US7238366B1Jul 3, 2007

Submicron liposome suspensions obtained from preliposome lyophilizates

UNIV TEXAS24 citations91
US5902604AMay 11, 1999

Submicron liposome suspensions obtained from preliposome lyophilizates

UNIV TEXAS29 citations91
US7745468B2Jun 29, 2010

Compounds for treatment of cell proliferative diseases

UNIV TEXAS12 citations90
US5132290AJul 21, 1992

Esters of 3'-deaminodoxorubicin and liposomal compositions thereof

UNIV TEXAS11 citations74
US6437105B1Aug 20, 2002

Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents

UNIV TEXAS11 citations72
US11026960B2Jun 8, 2021

Esters of 2-deoxy-monosaccharides with anti proliferative activity

UNIV TEXAS1 citations71
US10201554B2Feb 12, 2019

Esters of 2-deoxy-monosacharides with anti proliferative activity

UNIV TEXAS2 citations71
US12257262B2Mar 25, 2025

Method of reconstituting liposomal annamycin

UNIV TEXAS1 citations61
US12257261B2Mar 25, 2025

Preparation of preliposomal Annamycin lyophilizate

UNIV TEXAS1 citations61
US11925654B2Mar 12, 2024

Esters of 2-deoxy-monosaccharides with anti proliferative activity

UNIV TEXAS0 citations61
US9000179B2Apr 7, 2015

Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

UNIV TEXAS1 citations61
US9096499B2Aug 4, 2015

Compounds for treatment of cell proliferative diseases

UNIV TEXAS1 citations60
US7365096B2Apr 29, 2008

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

UNIV TEXAS3 citations58
US5977327ANov 2, 1999

Synthesis of annamycin

UNIV TEXAS6 citations58
US10703721B2Jul 7, 2020

Caffeic acid derivatives and uses thereof

UNIV TEXAS1 citations53
US6680300B2Jan 20, 2004

Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents

UNIV TEXAS1 citations51
US7928062B2Apr 19, 2011

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

UNIV TEXAS0 citations48
US10358439B2Jul 23, 2019

DNA binding agents with a minor groove binding tail

UNIV TEXAS0 citations40

PRIEBE WALDEMAR

9 patents

HOUSTON PHARMACEUTICALS INC

3 patents

(unassigned)

2 patents

MOLECULIN BIOTECH INC

2 patents

UNIV OHIO STATE RES FOUND

2 patents

LAMPIDIS THEODORE J

1 patent

UNIV OHIO STATE

1 patent

RAUCHER DRAZEN

1 patent

US HEALTH

1 patent

OHIO STATE RES FOUND

1 patent